VCYT - VERACYTE, INC.

QQQ $ 441.01 $ 0.55 (0.12 %)

DIA $ 393.97 $ 3.86 (0.99 %)

SPY $ 519.77 $ 2.33 (0.45 %)

TLT $ 90.66 $ 0.63 (0.7 %)

GLD $ 216.36 $ 1.66 (0.77 %)

Previous Close

$ 20.12

Open

$ 20.09

Bid

$ 0.00 x 0

Ask

$ 20.84 x 100

Day's Range

$ 19.92 - $ 20.86

52 Week Range

$ 18.61 - $ 30.52

Volume

955,094

Average Volume

Market Cap

1.5B

Beta (5Y Monthly)

$ 1.76

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-08-2024	03-31-2024	10-Q
2	02-29-2024	12-31-2023	10-K
3	11-08-2023	09-30-2023	10-Q
4	08-09-2023	06-30-2023	10-Q
5	05-05-2023	03-31-2023	10-Q
6	03-01-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-03-2022	06-30-2022	10-Q
9	05-03-2022	03-31-2022	10-Q
10	02-28-2022	12-31-2021	10-K
11	11-09-2021	09-30-2021	10-Q
12	07-29-2021	06-30-2021	10-Q
13	05-10-2021	03-31-2021	10-Q
14	02-22-2021	12-31-2020	10-K
15	11-02-2020	09-30-2020	10-Q
16	07-30-2020	06-30-2020	10-Q
17	05-06-2020	03-31-2020	10-Q
18	02-25-2020	12-31-2019	10-K
19	10-22-2019	09-30-2019	10-Q
20	07-30-2019	06-30-2019	10-Q
21	04-30-2019	03-31-2019	10-Q
22	02-25-2019	12-31-2018	10-K
23	10-29-2018	09-30-2018	10-Q
24	07-23-2018	06-30-2018	10-Q
25	05-01-2018	03-31-2018	10-Q
26	02-27-2018	12-31-2017	10-K
27	11-07-2017	09-30-2017	10-Q
28	07-31-2017	06-30-2017	10-Q
29	05-03-2017	03-31-2017	10-Q
30	03-01-2017	12-31-2016	10-K
31	11-03-2016	09-30-2016	10-Q
32	08-03-2016	06-30-2016	10-Q
33	05-05-2016	03-31-2016	10-Q
34	03-14-2016	12-31-2015	10-K
35	11-05-2015	09-30-2015	10-Q
36	08-13-2015	06-30-2015	10-Q
37	05-15-2015	03-31-2015	10-Q
38	03-25-2015	12-31-2014	10-K
39	11-13-2014	09-30-2014	10-Q
40	08-14-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

A Glimpse Into The Expert Outlook On Verac...
05/08/2024 15:00:33

Needham Maintains Buy on Veracyte, Lowers ...
05/08/2024 12:14:43

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $33 to $27.

Veracyte Q1 2024 GAAP EPS $(0.02) Beats $(...
05/07/2024 22:17:19

Veracyte (NASDAQ:VCYT) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.17) by 8...

Veracyte Raises FY24 Revenue From $394M-$4...
05/07/2024 21:39:52

Veracyte Announces Data From 14 Studies Pr...
05/06/2024 20:30:52

Large number of abstracts also showcases power of the Veracyte Diagnostics PlatformVeracyte, Inc. (NASDAQ:VCYT), a leading canc...

Veracyte's New Study Shows The Decipher Pr...
04/22/2024 12:42:54

Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that a new study published in JCO Precision...

Veracyte Announces 9 Abstracts Reinforcing...
04/16/2024 12:42:48

Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that nine abstracts focused on its Decipher...

Goldman Sachs Maintains Buy on Veracyte, L...
04/15/2024 14:33:35

Goldman Sachs analyst Matthew Sykes maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $32 to $28.

cathie-woods-ark-invest-dumps-17m-in-coinbase-shares-as-the-exchange-grappled-with-disruption-amid-bitcoin-rally

Cathie Wood's Ark Invest Dumps $17M In Coi...
02/29/2024 04:02:13

On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling over $17 million worth of Coinbase Global Inc (NASD...

cathie-woods-ark-invest-sheds-93m-worth-of-coinbase-shares-amid-bitcoin-rally--robinhood-stock-also-sold

Cathie Wood's Ark Invest Sheds $9.3M Worth...
02/28/2024 03:35:54

On Tuesday, Cathie Wood-led Ark Invest adjusted its portfolio, making significant trades.

cathie-woods-ark-invest-offloads-69m-worth-of-coinbase-robinhood-shares-each-amid-searing-bitcoin-rally--nvidia-stock-also-shed

Cathie Wood's Ark Invest Offloads $6.9M Wo...
02/27/2024 03:45:00

On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such a...

Morgan Stanley Maintains Underweight on Ve...
02/26/2024 16:16:42

Morgan Stanley analyst Tejas Savant maintains Veracyte (NASDAQ:VCYT) with a Underweight and lowers the price target from $22...

Needham Maintains Buy on Veracyte, Raises ...
02/23/2024 10:34:34

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $30 to $33.

Veracyte Sees FY24 Revenue $394M-$402M Vs ...
02/22/2024 22:17:55

Recap: Veracyte Q4 Earnings
02/22/2024 21:55:23

Veracyte Q4 2023 Adj EPS $0.05 Beats $(0.0...
02/22/2024 21:54:41

Veracyte (NASDAQ:VCYT) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.09) by 1...

Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

Earnings Outlook For Veracyte
02/21/2024 17:01:04

cathie-woods-ark-invest-buys-over-92m-worth-of-proshares-bitcoin-etf-sells-coinbase-block-and-palantir-shares

Cathie Wood's Ark Invest Buys Over $92M Wo...
12/28/2023 04:19:54

On Wednesday, Cathie Wood-led Ark Invest made a significant move in the cryptocurrency space, purchasing over $92 million worth...

Clinical Validation Data Published In CHES...
11/29/2023 13:35:45

Non-invasive genomic test is designed to help physicians guide next steps for current and former smokers with lung nodulesVerac...